New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 25, 2014
08:43 EDTILMNIllumina sell-off a buying opportunity, says at UBS
UBS said there is no change in Illumina fundamentals and would use recent weakness ass a buying opportunity. Shares are Buy rated with a $202 price target.
News For ILMN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 16, 2014
10:01 EDTILMNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:33 EDTILMNIllumina upgraded to Overweight from Neutral at Piper Jaffray
Subscribe for More Information
October 15, 2014
06:32 EDTILMNIllumina to invest in three genomics industry startups
Illumina selected three startup companies for the inaugural Illumina Accelerator funding cycle. The companies are Encoded Genomics, EpiBiome and Xcell Biosciences. The Illumina Accelerator will provide selected startups with seed investment, business guidance, access to Illumina’s sequencing systems and reagents, and fully operational lab space in the San Francisco Bay Area during the six-month cycle.
October 14, 2014
08:15 EDTILMNIllumina should report stronger than expected results, says Wedbush
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use